MeiraGTx Holdings (STU:328) PB Ratio: (As of Jul. 06, 2026)


STU:328 MeiraGTx Holdings PLC STU:328
56 GF Score
Price €12.10
GF Value €20.56
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is MeiraGTx Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-06), MeiraGTx Holdings's share price is €12.10. MeiraGTx Holdings's Book Value per Share for the quarter that ended in Mar. 2026 was €-0.62. Hence, MeiraGTx Holdings's PB Ratio of today is .

The historical rank and industry rank for MeiraGTx Holdings's PB Ratio or its related term are showing as below:

During the past 10 years, MeiraGTx Holdings's highest PB Ratio was 232.97. The lowest was 1.82. And the median was 3.12.

STU:328's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.99
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, MeiraGTx Holdings's average Book Value Per Share Growth Rate was -271.20% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of MeiraGTx Holdings was 12.00% per year. The lowest was -40.80% per year. And the median was -24.25% per year.

Back to Basics: PB Ratio


MeiraGTx Holdings  (STU:328) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


MeiraGTx Holdings PB Ratio Related Terms


MeiraGTx Holdings PB Ratio Historical Data

* Premium members only.

The historical data trend for MeiraGTx Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeiraGTx Holdings PB Ratio Chart

MeiraGTx Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.59 2.57 3.19 7.08 0.00

MeiraGTx Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.93 170.31 0.00 0.00 0.00

STU:328 vs XNCR, WVE, CGEM: PB Ratio Comparison

For the Biotechnology subindustry, MeiraGTx Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeiraGTx Holdings PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MeiraGTx Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where MeiraGTx Holdings's PB Ratio falls into.


STU:328
56GF Score
MeiraGTx Holdings PLC STU:328
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeiraGTx Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

MeiraGTx Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=12.10/-0.617
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is MeiraGTx Holdings (STU:328) Overvalued in 2026?

Based on GuruFocus' analysis, MeiraGTx Holdings stock appears to be undervalued. The current stock price of €12.10 is trading 41.1% below its estimated GF Value™ of €20.56. GuruFocus considers MeiraGTx Holdings to be Possible Value Trap.

Key valuation signals for STU:328:

  • PB Ratio:
  • GF Value™: €20.56 vs. price of €12.10 (41.1% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the STU:328 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeiraGTx Holdings Business Description

Other Exchanges MGTX:USA
Address 655 Third Avenue, Suite 1115, New York, NY, USA, 10017
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
56GF Score

Get the complete analysis for STU:328

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.10
Price
€20.56
GF Value